Comparison of adenoviral and adeno-associated viral vectors for pancreatic gene delivery in vivo

Human Gene Therapy

Volumn 15, Issue 4, 2004, Pages 405-413

  Wang, Alfred Y ^a   Peng, Peter D ^a   Ehrhardt, Anja ^a   Storm, Theresa A ^a   Kay, Mark A ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; BETA GALACTOSIDASE; GLUCOSE; INSULIN; PARVOVIRUS VECTOR;

ACINAR CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; ENDOCRINE CELL; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; LEUKOCYTE; MALE; MOUSE; NONHUMAN; PANCREAS; REPORTER GENE; SEROTYPE; TRANSGENE; VIRAL GENE DELIVERY SYSTEM;

ADENOVIRIDAE; AMYLASES; ANIMALS; BLOOD GLUCOSE; DEPENDOVIRUS; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; LAC OPERON; LEUKOCYTES; MALE; MICE; MICE, INBRED C57BL; PANCREAS; TRANSDUCTION, GENETIC;

ADENO-ASSOCIATED VIRUS; ADENOVIRIDAE; ANIMALIA; DNA VIRUSES; PARVOVIRUS;

EID: 1842636251     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/104303404322959551     Document Type: Article

References (30)

1. BOTTINO, R., LEMARCHAND, P., TRUCCO, M., and GIANNOUKAKIS, N. (2003). Gene-and cell-based therapeutics for type I diabetes mellitus. Gene Ther. 10, 875-889.
2. BREYER, B., JIANG, W., CHENG, H., ZHOU, L., PAUL, R., FENG, T., and HE, T.C. (2001). Adenoviral vector-mediated gene transfer for human gene therapy. Curr. Gene Ther. 1, 149-162.
3. CARTER, P.J., and SAMULSKI, R.J. (2000). Adeno-associated viral vectors as gene delivery vehicles. Int. J. Mol. Med. 6, 17-27.
4. EDLUND, H. (2002). Pancreatic organogenesis: Developmental mechanisms and implications for therapy. Nat. Rev. Genet. 3, 524-532.
5. EHRHARDT, A., and KAY, M.A. (2002). A new adenoviral helper-dependent vector results in long-term therapeutic levels of human coagulation factor IX at low doses in vivo. Blood 99, 3923-3930.
6. FLOTTE, T., AGARWAL, A., WANG, J., SONG, S., FENJVES, E.S., INVERARDI, L., CHESNUT, K. AHONE, S., LOILER, S., WASSERFALL, C., KAPTURCZAK, M., ELLIS, T., NICK, H., and ATKINSON, M. (2001). Efficient ex vivo transduction of pancreatic islet cells with recombinant adeno-associated virus vectors. Diabetes 50, 515-552.
7. GAO, G., ALVIRA, M.R., WANG, L., CALCEDO, R., JOHNSTON, J., and WILSON, J.M. (2002). Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy. Proc. Natl. Acad. Sci. U.S.A. 99, 11854-11859.
8. GRIMM, D., and KAY, M.A. (2003a). From virus evolution to vector revolution: Use of naturally occurring serotypes of adeno-associated virus (AAV) as novel vectors for human gene therapy. Curr. Gene Ther. 3, 281-304.
9. GRIMM, D., KAY, M.A., and KLEINSCHMIDT, J. (2003b). Helper virus-free, optically controllable, and two-plasmid-based production of adeno-associated virus vectors of serotypes 1 to 6. Mol. Ther. 7, 839-850.
10. KAPTURCZAK, M.H., FLOTTE, T., and ATKINSON, M.A. (2001). Adeno-associated virus (AAV) as a vehicle for therapeutic gene delivery: Improvements in vector design and viral production enhance potential to prolong graft survival in pancreatic islet transplantation for the reversal of type 1 diabetes. Curr. Mol. Med. 1, 245-258.
11. KAY, M.A., LI Q.T., LIU, T.J., LELAND, F., FINEGOLD, M., and WOO, S.L.C. (1992). Direct hepatic gene delivery in mice results in persistent expression of human alpha-1-antitrypsin in vivo. Hum. Gene Ther. 3, 641-647.
12. KAY, M.A., LANDEN, C.N., ROTHENBERG, S.R., TAYLOR, L.A., LELAND, F., WIEHLE, S., FANG, B., BELLINGER, D., FINEGOLD, M., THOMPSON, A.R., READ, M., BRINKHOUS, K.M., and WOO S.L.C. (1994). In vivo hepatic gene therapy: Complete albeit transient correction of factor IX deficiency in hemophilia B dogs. Proc. Natl. Acad. Sci. U.S.A. 91, 2353-2357.
13. LEDBETTER, J.A., and HERZENBERG, L.A. (1979). Xenogeneic monoclonal antibodies to mouse lymphoid differentiation antigens. Immunol. Rev. 47, 63-90.
14. 3H]-Thymidine autoradiographic investigation. Pancreas 24, 153-160.
15. MCCLANE, S.J., HAMILTON, T.E., DEMATTEO R.P., BURKE, C., and RAPER, S.E. (1997a). Effect of adenoviral early genes and the host immune response system on in vivo pancreatic gene transfer in the mouse. Pancreas 15, 236-245.
16. MCCLANE, S.J., HAMILTON, T.E., BURKE, C.V., and RAPER, S.E. (1997b). Functional consequences of adenovirus-mediated murine pancreas gene transfer. Hum. Gene Ther. 8, 739-746.
17. MONAHAN, P.E., and SAMULSKI, R.J. (2000). AAV vectors: Is clinical success on the horizon? Gene Ther. 7, 24-30.
18. MORIDANI, M.Y., and BROMBERG, I.L. (2003). Lipase and pancreatic amylase versus total amylase as biomarkers of pancreatitis: An analytical investigation. Clin. Biochem. 36, 31-33.
19. NAKAI, H., STORM, T.A., and KAY, M.A. (2000). Increasing the size of rAAV-mediated expression cassettes in vivo by intermolecular joining of two complementary vectors. Nat. Biotechnol. 18, 527-532.
20. PARK, F., OHASHI, K., CHIU, W., and KAY, M.A. (2000). Efficient lentiviral transduction of liver requires cell cycling in vivo. Nat. Genet. 24, 49-52.
21. PRASAD, K.M., YANG, Z., BLEICH, D., and NADLER, J.L. (2000). Adeno-associated virus vector mediated gene transfer to pancreatic beta cells. Gene Ther. 7, 1553-1561.
22. PRUDHOMME, G.J. (2000). Gene therapy of autoimmune diseases with vectors encoding regulatory cytokines or inflammatory cytokine inhibitors. J. Gene Med. 2, 222-232.
23. RAPER, S.E., and DEMATTEO, R.P. (1996). Adenovirus-mediated in vivo gene transfer and expression in normal rat pancreas. Pancreas 12, 401-410.
24. RUTLEDGE, E.A., HALBERT, C.L., and RUSSELL, D.W. (1998). Infectious clones and vectors derived from adeno-associated virus (AAV) serotypes other than AAV type 2. J. Virol. 72, 309-319.
25. SNYDER, R.O. (1999). Adeno-associated virus-mediated gene delivery. J. Gene Med. 1, 166-175.
26. SNYDER, R.O., MIAO, C.H., PATIJN, G.J., PRATT, S.K., DANOS, O., GOWN, A.M., WINTHER, B., MEUSE, L., COHEN, L.K., THOMPSON, A.R., and KAY, M.A. (1997). Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors. Nat. Genet. 16, 270-276.
27. STILWELL, J.L., and SAMULSKI, R.J. (2003). Adeno-associated virus vectors for therapeutic gene transfer. Biotechniques 34, 148-150.
28. THOMAS, C.E., STORM, T.A., HUANG, Z., and KAY, M.A. (2004). Rapid uncoating of vector genomes is the key to efficient liver transduction with AAV pseudotyped vectors. J. Virol. (in press).
29. YANT, S.R., EHRHARDT, A., MIKKELSEN, J.G., MEUSE, L., PHAM, T., KAY, M.A. (2002). Transposition from a gutless adeno-transposon vector stabilizes transgene expression in vivo. Nat. Biotechnol. 20, 999-1005.
30. ZAISS, A.K., LIU, Q., BOWEN, G.P., WONG, N.C., BARTLETT, J.S., and MURUVE, D.A. (2002). Differential activation of innate immune responses by adenovirus and adeno-associated virus vectors. J. Virol. 76, 4580-4590.